Alphabet Inc (NASDAQ:GOOGL) Chief Executive Officer Larry Page was ordered to submit to questioning by Uber Technologies Inc. in his company’s lawsuit over trade secrets for self-driving car technology.
Uber’s lawyers want to question Page in their defense against the allegations the ride-hailing company stole technology central to the development of autonomous vehicles by Alphabet’s Waymo unit. Waymo argued the deposition of Page was unnecessary and intrusive, but a San Francisco federal magistrate judge said Friday he can be questioned for as long as four hours. “Larry Page has first-hand non-repetitive knowledge of relevant facts,” U.S. Magistrate Judge Jacqueline Scott Corley wrote.
On Friday Alphabet Inc (NASDAQ:GOOGL) share price closed at $940.81. Company net profit margin stands at 21.80% whereas its return on equity (ROE) is 15.20%. Alphabet Inc (NASDAQ:GOOGL) is -6.72% away from its 52 week high.
Merck & Co., Inc. (NYSE:MRK) said the U.S. Food and Drug Administration had placed a clinical hold on three multiple myeloma studies testing its Keytruda in combination with other medicines for the blood cancer after more deaths were reported in patients receiving the Merck immunotherapy.
Merck has been on a roll with the medicine, jumping to the front of the pack of companies with new immuno-oncology drugs, particularly after Keytruda extended survival as an initial treatment for advanced lung cancer, by far the largest oncology market. Bristol-Myers Squibb (BMY.N) had been the perceived leader in the field until last year, when its Opdivo failed to match Keytruda’s lung cancer success.
Merck last month said it had stopped enrolling patients in the trials testing Keytruda in combination with standard multiple myeloma regimens including Celgene Corp drugs. The decision was taken after independent safety monitors observed more deaths in patients receiving the Keytruda combination than in the control groups in two of the studies.
Merck & Co., Inc. (NYSE:MRK) traded 6.9 Million shares and its share price moved up 0.10% to close at $63.16. Company has 0.04% insider ownership. Merck & Co., Inc. (NYSE:MRK) quarterly performance is -0.13% while its year to date (YTD) performance is 7.29%.
On Friday shares of GNC Holdings, Inc. (NYSE:GNC) ended up at $8.33. This year Company’s Earnings per Share (EPS) growth is -258.30% and next year’s EPS growth is -2.81%. Beta of GNC Holdings, Inc. (NYSE:GNC) is 0.83 while company weekly performance is 0.12%.
McDonald’s Corporation (NYSE:MCD) moved up 2.08% to close at $156.27 on 07 July. Its return on assets (ROA) is 14.80% while return on investment (ROI) is 23.40%. McDonald’s Corporation (NYSE:MCD) price to sales (P/S) ratio is 5.22.